Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 1248201, 15 pages
https://doi.org/10.1155/2017/1248201
Research Article

ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes

Institute of Virology, University of Cologne, Fürst-Pückler-Strasse 56, 50935 Cologne, Germany

Correspondence should be addressed to Gertrud Steger; ed.nleok-inu@regets.durtreg

Received 28 October 2016; Accepted 5 January 2017; Published 21 February 2017

Academic Editor: Anshu Agrawal

Copyright © 2017 Linda Schroeder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. M. Schneider, M. D. Chevillotte, and C. M. Rice, “Interferon-stimulated genes: a complex web of host defenses,” Annual Review of Immunology, vol. 32, pp. 513–545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. McLaren and D. P. Ramji, “Interferon gamma: a master regulator of atherosclerosis,” Cytokine and Growth Factor Reviews, vol. 20, no. 2, pp. 125–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Billottet, C. Quemener, and A. Bikfalvi, “CXCR3, a double-edged sword in tumor progression and angiogenesis,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1836, no. 2, pp. 287–295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Karin, G. Wildbaum, and M. Thelen, “Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets,” Journal of Leukocyte Biology, vol. 99, no. 6, pp. 857–862, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Van Raemdonck, P. E. Van den Steen, S. Liekens, J. Van Damme, and S. Struyf, “CXCR3 ligands in disease and therapy,” Cytokine and Growth Factor Reviews, vol. 26, no. 3, pp. 311–327, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. A. C. Huen and A. Wells, “The beginning of the end: CXCR3 signaling in late-stage wound healing,” Advances in Wound Care, vol. 1, no. 6, pp. 244–248, 2012. View at Publisher · View at Google Scholar
  7. J. P. Strassner and J. E. Harris, “Understanding mechanisms of autoimmunity through translational research in vitiligo,” Current Opinion in Immunology, vol. 43, pp. 81–88, 2016. View at Publisher · View at Google Scholar
  8. J. M. Richmond, D. S. Bangari, K. I. Essien et al., “Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease,” Journal of Investigative Dermatology, 2016. View at Publisher · View at Google Scholar
  9. A. Chariot, “The NF-κB-independent functions of IKK subunits in immunity and cancer,” Trends in Cell Biology, vol. 19, no. 8, pp. 404–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Boeckle, H. Pfister, and G. Steger, “A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2,” Virology, vol. 293, no. 1, pp. 103–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Tanaka, J. Shouguchi-Miyata, N. Miyamoto, and J.-E. Ikeda, “Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene,” The Journal of Biological Chemistry, vol. 279, no. 8, pp. 7275–7286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Jordanovski, C. Herwartz, A. Pawlowski, S. Taute, P. Frommolt, and G. Steger, “The hypoxia-inducible transcription factor ZNF395 is controlled by IKB kinase-signaling and activates genes involved in the innate immune response and cancer,” PLoS ONE, vol. 8, no. 9, Article ID e74911, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. A. Atcha, A. Syed, B. Wu et al., “A unique DNA binding domain converts T-cell factors into strong Wnt effectors,” Molecular and Cellular Biology, vol. 27, no. 23, pp. 8352–8363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Ravindranath and K. M. Cadigan, “Structure-function analysis of the C-clamp of TCF/Pangolin in Wnt/ss-catenin signaling,” PLoS ONE, vol. 9, no. 1, Article ID e86180, 2014. View at Google Scholar
  15. N. P. Hoverter, J.-H. Ting, S. Sundaresh, P. Baldi, and M. L. Waterman, “A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs,” Molecular and Cellular Biology, vol. 32, no. 18, pp. 3648–3662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Cadigan and M. L. Waterman, “TCF/LEFs and Wnt signaling in the nucleus,” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Sichtig, N. Körfer, and G. Steger, “Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex,” Archives of Biochemistry and Biophysics, vol. 467, no. 1, pp. 67–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Goodarzi, S. Zhang, C. G. Buss, L. Fish, S. Tavazoie, and S. F. Tavazoie, “Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins,” Nature, vol. 513, no. 7517, pp. 256–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Pang, R. Zha, Y. Zhao et al., “MiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395,” PLoS ONE, vol. 9, no. 3, Article ID e90867, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Fardin, A. Barla, S. Mosci et al., “A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients,” Molecular Cancer, vol. 9, article no. 185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Murat, E. Migliavacca, S. F. Hussain et al., “Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia,” PLoS ONE, vol. 4, no. 6, Article ID e5947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Tsukahara, S. Kimura, S. Ichimiya et al., “Scythe/BAT3 regulates apoptotic cell death induced by papillomavirus binding factor in human osteosarcoma,” Cancer Science, vol. 100, no. 1, pp. 47–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Tsukahara, Y. Nabeta, S. Kawaguchi et al., “Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor,” Cancer Research, vol. 64, no. 15, pp. 5442–5448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Yabe, T. Tsukahara, S. Kawaguchi et al., “Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis,” Oncology Reports, vol. 19, no. 1, pp. 129–134, 2008. View at Google Scholar · View at Scopus
  25. K. M. Skubitz, W. Zimmerman, R. Kammerer, S. Pambuccian, and A. P. N. Skubitz, “Differential gene expression identifies subgroups of renal cell carcinoma,” Journal of Laboratory and Clinical Medicine, vol. 147, no. 5, pp. 250–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. S. Dalgin, D. T. Holloway, L. S. Liou, and C. DeLisi, “Identification and characterization of renal cell carcinoma gene markers,” Cancer Informatics, vol. 3, pp. 65–92, 2007. View at Google Scholar · View at Scopus
  27. A. Lal, H. Peters, B. St Croix et al., “Transcriptional response to hypoxia in human tumors,” Journal of the National Cancer Institute, vol. 93, no. 17, pp. 1337–1343, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Elvidge, L. Glenny, R. J. Appelhoff, P. J. Ratcliffe, J. Ragoussis, and J. M. Gleadle, “Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways,” Journal of Biological Chemistry, vol. 281, no. 22, pp. 15215–15226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Jordanovski, C. Koehler, and G. Steger, ZNF395 (HDBP2/PBF) Is a Target Gene of HIF1alpha. Huntington's Disease-Core Concepts and Current Advances, InTech, Rijeka, Croatia, 2012.
  30. C. Herwartz, P. Castillo-Juárez, L. Schröder, B. L. Barron, and G. Steger, “The transcription factor ZNF395 is required for the maximal hypoxic induction of proinflammatory cytokines in U87-MG cells,” Mediators of Inflammation, vol. 2015, Article ID 804264, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. Eltzschig and P. Carmeliet, “Hypoxia and inflammation,” New England Journal of Medicine, vol. 364, no. 7, pp. 656–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. M. L. Hertoghs, P. D. Moerland, A. Van Stijn et al., “Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation,” Journal of Clinical Investigation, vol. 120, no. 11, pp. 4077–4090, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Rotger, K. K. Dang, J. Fellay et al., “Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals,” PLoS Pathogens, vol. 6, no. 2, Article ID e1000781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Q. Wu, D. E. Dwyer, W. B. Dyer, Y. H. Yang, B. Wang, and N. K. Saksena, “Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses,” Virology, vol. 380, no. 1, pp. 124–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. C. Greenough, J. R. Straubhaar, L. Kamga et al., “A gene expression signature that correlates with CD8+ T cell expansion in acute EBV infection,” Journal of Immunology, vol. 195, no. 9, pp. 4185–4197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. K. J. Purdie, C. J. Sexton, C. M. Proby et al., “Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus?” Cancer Research, vol. 53, no. 21, pp. 5328–5333, 1993. View at Google Scholar · View at Scopus
  37. J. R. Burke, M. A. Pattoli, K. R. Gregor et al., “BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1450–1456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. C. L. Spurrell, S. Wiehler, R. S. Zaheer, S. P. Sanders, and D. Proud, “Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 289, no. 1, pp. L85–L95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Mercurio, H. Zhu, B. W. Murray et al., “IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation,” Science, vol. 278, no. 5339, pp. 860–866, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, article no. e45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Rincon-Orozco, G. Halec, S. Rosenberger et al., “Epigenetic silencing of interferon-κ in human papillomavirus type 16-positive cells,” Cancer Research, vol. 69, no. 22, pp. 8718–8725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. P. J. McLaren, A. Gawanbacht, N. Pyndiah et al., “Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses,” Retrovirology, vol. 12, no. 1, article no. 41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. D. Barr, J. R. Smiley, and F. D. Bushman, “The interferon response inhibits HIV particle production by induction of TRIM22,” PLoS Pathogens, vol. 4, no. 2, article no. e1000007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. W. Woods, J. N. Kelly, C. J. Hattlmann et al., “Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag,” Retrovirology, p. 95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. W. Woods, J. G. Tong, S. K. Tom et al., “Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export,” Retrovirology, vol. 11, no. 1, article 27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Goujon, O. Moncorgé, H. Bauby et al., “Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection,” Nature, vol. 502, no. 7472, pp. 559–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Liu, Q. Pan, S. Ding et al., “The interferon-inducible MxB protein inhibits HIV-1 infection,” Cell Host and Microbe, vol. 14, no. 4, pp. 398–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. D. J. Morales and D. J. Lenschow, “The antiviral activities of ISG15,” Journal of Molecular Biology, vol. 425, no. 24, pp. 4995–5008, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. D. W. LaFleur, B. Nardelli, T. Tsareva et al., “Interferon-κ, a novel type i interferon expressed in human keratinocytes,” Journal of Biological Chemistry, vol. 276, no. 43, pp. 39765–39771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Y. Low, M. Peng, R. Magliozzi, S. Mohammed, D. Guardavaccaro, and A. J. R. Heck, “A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase,” Science Signaling, vol. 7, no. 356, article rs8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. T. B. Loveless, B. R. Topacio, A. A. Vashisht et al., “DNA damage regulates translation through β-TRCP targeting of CReP,” PLoS Genetics, vol. 11, no. 6, Article ID e1005292, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Y. Kim, P. F. Siesser, K. L. Rossman et al., “Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase,” Molecular and Cellular Biology, vol. 35, no. 1, pp. 167–181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Coyaud, M. Mis, E. M. N. Laurent et al., “BioID-based identification of skp cullin F-box (SCF)βTrCP1/2 E3 ligase substrates,” Molecular and Cellular Proteomics, vol. 14, no. 7, pp. 1781–1795, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Y. Shin, J.-S. Nam, Y. Lim, and Y. H. Lee, “TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines,” The Journal of Biological Chemistry, vol. 285, no. 40, pp. 30731–30740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Frescas and M. Pagano, “Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer,” Nature Reviews Cancer, vol. 8, no. 6, pp. 438–449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Hinz and C. Scheidereit, “The IκB kinase complex in NF-κB regulation and beyond,” EMBO Reports, vol. 15, no. 1, pp. 46–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Christian, E. Smith, and R. Carmody, “The regulation of NF-κB subunits by phosphorylation,” Cells, vol. 5, no. 1, article no. 12, 2016. View at Publisher · View at Google Scholar
  58. S. J. Tudhope, M. C. Catley, P. S. Fenwick et al., “The role of IκB kinase 2, but not activation of NF-κB, in the release of CXCR3 ligands from IFN-γ-stimulated human bronchial epithelial cells,” Journal of Immunology, vol. 179, no. 9, pp. 6237–6245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. Du, M. A. Whitt, J. Baumann et al., “Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1,” Journal of Interferon and Cytokine Research, vol. 32, no. 8, pp. 368–377, 2012. View at Publisher · View at Google Scholar · View at Scopus